DrugBiological
Sotevtamab clinical trials
Keep track of what changes. Save the sotevtamab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Alethia Biotherapeutics (3) · ImmunityBio, Inc. (1)
Often tested with
Tested in the same studies.
Docetaxel (1) · Folfox protocol (1) · Nogapendekin alfa inbakicept (1) · Zabadinostat (1) · Albumin-Bound Paclitaxel (1) · Paclitaxel (1) · Gemcitabine (1)
Studies
Open first, then newest update. How each study uses sotevtamab is read from its arms, and is right about nine times in ten.
Testing it · 4
- Sotevtamab (AB-16B5) Combined With FOLFOX as Neoadjuvant Treatment Prior to Resection of Colorectal Cancer Liver MetastasisRecruitingPhase 2Alethia BiotherapeuticsNCT06225843Written as Sotevtamab
- Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic CancerWithdrawnPhase 1ImmunityBio, Inc.NCT07488884Written as Sotevtamab
- AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)CompletedPhase 2Alethia BiotherapeuticsNCT04364620Written as AB-16B5
- Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid MalignancyCompletedPhase 1Alethia BiotherapeuticsNCT02412462Written as AB-16B5
Codes
What other systems call sotevtamab · ClinicalTrials.gg INT018610
- UNII (FDA) YQ3YJK67AFSOTEVTAMABOne source FDA
- NCI Thesaurus C121778SotevtamabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | YQ3YJK67AF | SOTEVTAMAB | One source FDA |
| NCI Thesaurus | C121778 | Sotevtamab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.